| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 5.17e-07 | 8 | 43 | 3 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.10e-06 | 10 | 43 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 4.53e-06 | 2 | 43 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 4.53e-06 | 2 | 43 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone modifying activity | 9.11e-06 | 229 | 43 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 1.03e-05 | 20 | 43 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.36e-05 | 3 | 43 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.42e-05 | 303 | 43 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 4.51e-05 | 5 | 43 | 2 | GO:0030107 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 6.76e-05 | 6 | 43 | 2 | GO:0030109 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 9.45e-05 | 7 | 43 | 2 | GO:0023025 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.16e-04 | 44 | 43 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.80e-04 | 51 | 43 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 2.02e-04 | 10 | 43 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.14e-04 | 54 | 43 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.26e-04 | 55 | 43 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | IgM binding | 2.46e-04 | 11 | 43 | 2 | GO:0001791 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.92e-04 | 60 | 43 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 2.95e-04 | 12 | 43 | 2 | GO:0032396 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 4.23e-04 | 68 | 43 | 3 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 4.41e-04 | 69 | 43 | 3 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 4.67e-04 | 15 | 43 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 4.80e-04 | 71 | 43 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 5.33e-04 | 16 | 43 | 2 | GO:0023029 | |
| GeneOntologyMolecularFunction | mRNA regulatory element binding translation repressor activity | 6.04e-04 | 17 | 43 | 2 | GO:0000900 | |
| GeneOntologyMolecularFunction | p53 binding | 6.09e-04 | 77 | 43 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 6.32e-04 | 78 | 43 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 6.78e-04 | 18 | 43 | 2 | GO:0032393 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 7.57e-04 | 19 | 43 | 2 | GO:0032394 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 9.27e-04 | 21 | 43 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.22e-03 | 562 | 43 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.38e-03 | 102 | 43 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.42e-03 | 103 | 43 | 3 | GO:0008276 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.46e-03 | 104 | 43 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.50e-03 | 105 | 43 | 3 | GO:0008170 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.02e-03 | 31 | 43 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.16e-03 | 32 | 43 | 2 | GO:0042288 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 2.58e-03 | 35 | 43 | 2 | GO:0008157 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 2.72e-03 | 36 | 43 | 2 | GO:0019865 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.88e-03 | 37 | 43 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.39e-03 | 140 | 43 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 3.52e-03 | 41 | 43 | 2 | GO:0023023 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.78e-03 | 739 | 43 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 5.55e-03 | 167 | 43 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 5.61e-03 | 52 | 43 | 2 | GO:0042169 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 6.02e-03 | 172 | 43 | 3 | GO:0008757 | |
| GeneOntologyMolecularFunction | MHC protein binding | 6.94e-03 | 58 | 43 | 2 | GO:0042287 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 7.61e-03 | 1356 | 43 | 8 | GO:0060090 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.69e-03 | 188 | 43 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 7.98e-03 | 582 | 43 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 8.39e-03 | 64 | 43 | 2 | GO:0036002 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 8.90e-03 | 66 | 43 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 8.90e-03 | 66 | 43 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 9.97e-03 | 70 | 43 | 2 | GO:0003777 | |
| GeneOntologyMolecularFunction | coreceptor activity | 1.05e-02 | 72 | 43 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.06e-02 | 875 | 43 | 6 | GO:0019904 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 1.08e-02 | 213 | 43 | 3 | GO:0008168 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.13e-02 | 1160 | 43 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.15e-02 | 891 | 43 | 6 | GO:0008270 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.22e-02 | 417 | 43 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 1.24e-02 | 224 | 43 | 3 | GO:0016741 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.28e-02 | 1189 | 43 | 7 | GO:0046914 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.41e-02 | 84 | 43 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.45e-02 | 238 | 43 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.48e-02 | 86 | 43 | 2 | GO:0046332 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 2.54e-05 | 4 | 43 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | T cell proliferation involved in immune response | 6.33e-05 | 6 | 43 | 2 | GO:0002309 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrogen peroxide-mediated programmed cell death | 8.86e-05 | 7 | 43 | 2 | GO:1901300 | |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | 9.73e-05 | 361 | 43 | 6 | GO:0002366 | |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | 1.03e-04 | 365 | 43 | 6 | GO:0002263 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.27e-04 | 741 | 43 | 8 | GO:0006338 | |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | 1.69e-04 | 251 | 43 | 5 | GO:0002285 | |
| GeneOntologyBiologicalProcess | dendritic cell differentiation | 1.94e-04 | 54 | 43 | 3 | GO:0097028 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 2.53e-04 | 148 | 43 | 4 | GO:0002286 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular estrogen receptor signaling pathway | 2.77e-04 | 12 | 43 | 2 | GO:0033148 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.89e-06 | 109 | 43 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | mucus layer | 1.24e-05 | 3 | 43 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 1.47e-04 | 9 | 43 | 2 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 2.69e-04 | 12 | 43 | 2 | GO:0032997 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.94e-04 | 75 | 43 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 7.12e-04 | 85 | 43 | 3 | GO:0000118 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.42e-03 | 108 | 43 | 3 | GO:0034708 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 2.10e-03 | 33 | 43 | 2 | GO:0044665 | |
| HumanPheno | Abnormality of the hairline | 1.02e-07 | 294 | 17 | 9 | HP:0009553 | |
| HumanPheno | Hypertrichosis | KMT2A PACS2 SMPD4 KMT2D RERE SRCAP KIF26A CREBBP EP300 GATA1 | 1.68e-07 | 425 | 17 | 10 | HP:0000998 |
| HumanPheno | Congenital abnormal hair pattern | 2.55e-07 | 327 | 17 | 9 | HP:0011361 | |
| HumanPheno | Prominent digit pad | 3.41e-07 | 48 | 17 | 5 | HP:0011298 | |
| HumanPheno | Abnormal columella morphology | 4.27e-07 | 97 | 17 | 6 | HP:0009929 | |
| HumanPheno | Low hanging columella | 7.49e-07 | 56 | 17 | 5 | HP:0009765 | |
| HumanPheno | Gastroesophageal reflux | KMT2A PACS2 MUC5B KMT2D RERE SLC11A1 KMT2B SRCAP CREBBP EP300 | 1.07e-06 | 517 | 17 | 10 | HP:0002020 |
| HumanPheno | Abnormal nasal septum morphology | 1.17e-06 | 115 | 17 | 6 | HP:0000419 | |
| HumanPheno | Abnormal hair pattern | KMT2A PACS2 SMPD4 KMT2D RERE SRCAP KIF26A CREBBP CAPRIN1 EP300 GATA1 | 1.21e-06 | 676 | 17 | 11 | HP:0010720 |
| HumanPheno | Abnormal size of the palpebral fissures | 1.91e-06 | 298 | 17 | 8 | HP:0200007 | |
| HumanPheno | Short columella | 1.92e-06 | 29 | 17 | 4 | HP:0002000 | |
| HumanPheno | Broad eyebrow | 1.92e-06 | 29 | 17 | 4 | HP:0011229 | |
| HumanPheno | Clinodactyly of the 5th finger | 2.16e-06 | 420 | 17 | 9 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 2.21e-06 | 421 | 17 | 9 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 2.21e-06 | 421 | 17 | 9 | HP:0009179 | |
| HumanPheno | Abnormal mandible morphology | KMT2A SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP CAPRIN1 EP300 DZIP1L ATPAF2 GATA1 | 2.51e-06 | 1118 | 17 | 13 | HP:0000277 |
| HumanPheno | Pilomatrixoma | 2.56e-06 | 9 | 17 | 3 | HP:0030434 | |
| HumanPheno | Abnormality of the scalp hair | 2.80e-06 | 433 | 17 | 9 | HP:0100037 | |
| HumanPheno | Abnormal stomach morphology | KMT2A PACS2 MUC5B KMT2D RERE SLC11A1 KMT2B SRCAP KIF26A CREBBP EP300 | 3.12e-06 | 742 | 17 | 11 | HP:0002577 |
| HumanPheno | Abnormal earlobe morphology | 3.29e-06 | 137 | 17 | 6 | HP:0000363 | |
| HumanPheno | Radial deviation of finger | 3.73e-06 | 448 | 17 | 9 | HP:0009466 | |
| HumanPheno | Abnormal scalp morphology | 3.87e-06 | 450 | 17 | 9 | HP:0001965 | |
| HumanPheno | Finger clinodactyly | 4.02e-06 | 452 | 17 | 9 | HP:0040019 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 4.32e-06 | 456 | 17 | 9 | HP:0009485 | |
| HumanPheno | Abnormality of the jaws | KMT2A SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP CAPRIN1 EP300 DZIP1L ATPAF2 GATA1 | 4.56e-06 | 1175 | 17 | 13 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | KMT2A SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP CAPRIN1 EP300 DZIP1L ATPAF2 GATA1 | 4.61e-06 | 1176 | 17 | 13 | HP:0030791 |
| HumanPheno | Thin upper lip vermilion | 5.07e-06 | 339 | 17 | 8 | HP:0000219 | |
| HumanPheno | Thin lips | 5.07e-06 | 339 | 17 | 8 | HP:0000213 | |
| HumanPheno | Plantar crease between first and second toes | 1.05e-05 | 2 | 17 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.05e-05 | 2 | 17 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 1.05e-05 | 2 | 17 | 2 | HP:0001042 | |
| HumanPheno | Abnormal 5th finger morphology | 1.08e-05 | 509 | 17 | 9 | HP:0004207 | |
| HumanPheno | Functional abnormality of the gastrointestinal tract | KMT2A PACS2 MUC5B KMT2D RERE SLC11A1 KMT2B SRCAP KIF26A CREBBP CAPRIN1 EP300 DZIP1L | 1.15e-05 | 1270 | 17 | 13 | HP:0012719 |
| HumanPheno | Prominent fingertip pads | 1.27e-05 | 46 | 17 | 4 | HP:0001212 | |
| HumanPheno | Abnormal esophagus morphology | KMT2A PACS2 MUC5B KMT2D RERE SLC11A1 KMT2B SRCAP CREBBP CAPRIN1 EP300 DZIP1L | 1.63e-05 | 1078 | 17 | 12 | HP:0002031 |
| HumanPheno | Deviation of finger | 1.68e-05 | 537 | 17 | 9 | HP:0004097 | |
| HumanPheno | Smooth philtrum | 1.88e-05 | 185 | 17 | 6 | HP:0000319 | |
| HumanPheno | Abnormal hair quantity | KMT2A PACS2 SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP EP300 GATA1 | 1.90e-05 | 888 | 17 | 11 | HP:0011362 |
| HumanPheno | Premature thelarche | 2.04e-05 | 17 | 17 | 3 | HP:0010314 | |
| HumanPheno | Hypermetropia | 2.04e-05 | 288 | 17 | 7 | HP:0000540 | |
| HumanPheno | Skin appendage neoplasm | 2.44e-05 | 18 | 17 | 3 | HP:0012842 | |
| HumanPheno | Abnormality of globe location | KMT2A PACS2 SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP CAPRIN1 EP300 GATA1 | 2.51e-05 | 1122 | 17 | 12 | HP:0100886 |
| HumanPheno | Deviation of the hand or of fingers of the hand | 2.52e-05 | 564 | 17 | 9 | HP:0009484 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | KMT2A KMT2D RERE SRCAP KIF26A CREBBP CAPRIN1 EP300 DZIP1L ATPAF2 GATA1 | 2.55e-05 | 915 | 17 | 11 | HP:0009116 |
| HumanPheno | Clinodactyly | 2.91e-05 | 574 | 17 | 9 | HP:0030084 | |
| HumanPheno | Low posterior hairline | 2.91e-05 | 117 | 17 | 5 | HP:0002162 | |
| HumanPheno | Abnormality of the posterior hairline | 2.91e-05 | 117 | 17 | 5 | HP:0030141 | |
| HumanPheno | Bulbous nose | 3.01e-05 | 201 | 17 | 6 | HP:0000414 | |
| HumanPheno | Abnormal esophagus physiology | KMT2A PACS2 MUC5B KMT2D RERE SLC11A1 KMT2B SRCAP CREBBP CAPRIN1 EP300 | 3.09e-05 | 933 | 17 | 11 | HP:0025270 |
| HumanPheno | Thin vermilion border | 3.12e-05 | 433 | 17 | 8 | HP:0000233 | |
| HumanPheno | Laryngeal cartilage malformation | 3.14e-05 | 3 | 17 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 3.14e-05 | 3 | 17 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 3.14e-05 | 3 | 17 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 3.14e-05 | 3 | 17 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 3.14e-05 | 3 | 17 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 3.14e-05 | 3 | 17 | 2 | HP:0005895 | |
| HumanPheno | Abnormal fingertip morphology | 3.19e-05 | 203 | 17 | 6 | HP:0001211 | |
| HumanPheno | Absent earlobe | 3.40e-05 | 20 | 17 | 3 | HP:0000387 | |
| HumanPheno | Ptosis | KMT2A PACS2 KMT2D RERE KMT2B CREBBP CAPRIN1 EP300 ATPAF2 GATA1 | 3.45e-05 | 754 | 17 | 10 | HP:0000508 |
| HumanPheno | Facial hypertrichosis | 3.46e-05 | 206 | 17 | 6 | HP:0002219 | |
| HumanPheno | Abnormal location of ears | KMT2A SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP EP300 DZIP1L GATA1 | 3.51e-05 | 945 | 17 | 11 | HP:0000357 |
| HumanPheno | Abnormal neck morphology | KMT2A SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP EP300 GATA1 | 3.97e-05 | 766 | 17 | 10 | HP:0025668 |
| HumanPheno | Abnormality of the frontal hairline | 4.41e-05 | 215 | 17 | 6 | HP:0000599 | |
| HumanPheno | Hirsutism | 4.53e-05 | 216 | 17 | 6 | HP:0001007 | |
| HumanPheno | Long eyelashes | 4.67e-05 | 129 | 17 | 5 | HP:0000527 | |
| HumanPheno | Epicanthus | 5.03e-05 | 614 | 17 | 9 | HP:0000286 | |
| HumanPheno | Abnormality of upper lip vermillion | 5.18e-05 | 464 | 17 | 8 | HP:0011339 | |
| HumanPheno | Abnormality of the forehead | KMT2A PACS2 SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP CAPRIN1 EP300 GATA1 | 5.54e-05 | 1208 | 17 | 12 | HP:0000290 |
| HumanPheno | Simple ear | 5.99e-05 | 24 | 17 | 3 | HP:0020206 | |
| HumanPheno | Cafe-au-lait spot | 6.24e-05 | 137 | 17 | 5 | HP:0000957 | |
| HumanPheno | Trichiasis | 6.27e-05 | 4 | 17 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 6.27e-05 | 4 | 17 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 6.27e-05 | 4 | 17 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 6.27e-05 | 4 | 17 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 6.27e-05 | 4 | 17 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 6.27e-05 | 4 | 17 | 2 | HP:0031207 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | KMT2A KMT2D RERE SRCAP KIF26A CREBBP CAPRIN1 EP300 DZIP1L ATPAF2 GATA1 | 6.60e-05 | 1008 | 17 | 11 | HP:0009122 |
| HumanPheno | Abnormality of globe location or size | KMT2A PACS2 SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP CAPRIN1 EP300 GATA1 | 7.70e-05 | 1246 | 17 | 12 | HP:0000489 |
| HumanPheno | Hypotelorism | 8.46e-05 | 146 | 17 | 5 | HP:0000601 | |
| HumanPheno | Low anterior hairline | 8.74e-05 | 147 | 17 | 5 | HP:0000294 | |
| HumanPheno | Micrognathia | KMT2A KMT2D RERE KIF26A CREBBP CAPRIN1 EP300 DZIP1L ATPAF2 GATA1 | 9.31e-05 | 843 | 17 | 10 | HP:0000347 |
| HumanPheno | Broad hallux | 9.40e-05 | 76 | 17 | 4 | HP:0010055 | |
| HumanPheno | Aplasia/Hypoplasia of the mandible | KMT2A KMT2D RERE KIF26A CREBBP CAPRIN1 EP300 DZIP1L ATPAF2 GATA1 | 9.51e-05 | 845 | 17 | 10 | HP:0009118 |
| HumanPheno | Coarctation of aorta | 9.63e-05 | 150 | 17 | 5 | HP:0001680 | |
| HumanPheno | Wide nasal bridge | 9.97e-05 | 508 | 17 | 8 | HP:0000431 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 1.04e-04 | 5 | 17 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 1.04e-04 | 5 | 17 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 1.04e-04 | 5 | 17 | 2 | HP:0030421 | |
| HumanPheno | Abnormality of the neck | KMT2A SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP EP300 GATA1 | 1.09e-04 | 858 | 17 | 10 | HP:0000464 |
| HumanPheno | Autistic behavior | 1.12e-04 | 678 | 17 | 9 | HP:0000729 | |
| HumanPheno | Retrognathia | 1.13e-04 | 375 | 17 | 7 | HP:0000278 | |
| HumanPheno | Short attention span | 1.13e-04 | 517 | 17 | 8 | HP:0000736 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 1.19e-04 | 30 | 17 | 3 | HP:0005743 | |
| HumanPheno | Abnormal epididymis morphology | 1.19e-04 | 30 | 17 | 3 | HP:0009714 | |
| HumanPheno | Abnormal pinna morphology | KMT2A SMPD4 KMT2D RERE KMT2B SRCAP KIF26A CREBBP CAPRIN1 EP300 DZIP1L GATA1 | 1.20e-04 | 1299 | 17 | 12 | HP:0000377 |
| HumanPheno | Reduced attention regulation | 1.28e-04 | 526 | 17 | 8 | HP:5200044 | |
| HumanPheno | Abnormal nasal tip morphology | 1.36e-04 | 386 | 17 | 7 | HP:0000436 | |
| HumanPheno | Deeply set eye | 1.46e-04 | 266 | 17 | 6 | HP:0000490 | |
| HumanPheno | Eversion of lateral third of lower eyelids | 1.56e-04 | 6 | 17 | 2 | HP:0007655 | |
| HumanPheno | Large foramen magnum | 1.56e-04 | 6 | 17 | 2 | HP:0002700 | |
| MousePheno | abnormal cell differentiation | LPIN3 KMT2A MMP9 KIF26A LILRB1 CREBBP LILRB5 DCLK1 CPEB4 GATA1 | 3.68e-05 | 795 | 38 | 10 | MP:0005076 |
| Domain | TIL | 3.98e-11 | 12 | 43 | 5 | PF01826 | |
| Domain | C8 | 3.98e-11 | 12 | 43 | 5 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 6.46e-11 | 13 | 43 | 5 | IPR014853 | |
| Domain | C8 | 6.46e-11 | 13 | 43 | 5 | SM00832 | |
| Domain | TIL_dom | 1.00e-10 | 14 | 43 | 5 | IPR002919 | |
| Domain | VWFD | 2.18e-10 | 16 | 43 | 5 | PS51233 | |
| Domain | VWD | 2.18e-10 | 16 | 43 | 5 | SM00216 | |
| Domain | VWF_type-D | 2.18e-10 | 16 | 43 | 5 | IPR001846 | |
| Domain | VWD | 2.18e-10 | 16 | 43 | 5 | PF00094 | |
| Domain | VWC_out | 5.77e-10 | 19 | 43 | 5 | SM00215 | |
| Domain | CT | 1.30e-09 | 22 | 43 | 5 | SM00041 | |
| Domain | Cys_knot_C | 2.61e-09 | 25 | 43 | 5 | IPR006207 | |
| Domain | CTCK_2 | 2.61e-09 | 25 | 43 | 5 | PS01225 | |
| Domain | VWF_dom | 4.06e-08 | 42 | 43 | 5 | IPR001007 | |
| Domain | CTCK_1 | 7.28e-08 | 18 | 43 | 4 | PS01185 | |
| Domain | FYrich_C | 1.13e-07 | 5 | 43 | 3 | IPR003889 | |
| Domain | FYrich_N | 1.13e-07 | 5 | 43 | 3 | IPR003888 | |
| Domain | FYRC | 1.13e-07 | 5 | 43 | 3 | SM00542 | |
| Domain | FYRN | 1.13e-07 | 5 | 43 | 3 | SM00541 | |
| Domain | FYRN | 1.13e-07 | 5 | 43 | 3 | PF05964 | |
| Domain | FYRC | 1.13e-07 | 5 | 43 | 3 | PF05965 | |
| Domain | FYRC | 1.13e-07 | 5 | 43 | 3 | PS51543 | |
| Domain | FYRN | 1.13e-07 | 5 | 43 | 3 | PS51542 | |
| Domain | WxxW_domain | 2.26e-07 | 6 | 43 | 3 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.26e-07 | 6 | 43 | 3 | PF13330 | |
| Domain | VWC | 1.70e-06 | 38 | 43 | 4 | SM00214 | |
| Domain | VWFC_2 | 1.70e-06 | 38 | 43 | 4 | PS50184 | |
| Domain | - | 5.18e-06 | 2 | 43 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 5.18e-06 | 2 | 43 | 2 | PF02135 | |
| Domain | ZF_TAZ | 5.18e-06 | 2 | 43 | 2 | PS50134 | |
| Domain | Nuc_rcpt_coact_CREBbp | 5.18e-06 | 2 | 43 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 5.18e-06 | 2 | 43 | 2 | PF08214 | |
| Domain | KIX | 5.18e-06 | 2 | 43 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 5.18e-06 | 2 | 43 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 5.18e-06 | 2 | 43 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 5.18e-06 | 2 | 43 | 2 | IPR013178 | |
| Domain | MeTrfase_trithorax | 5.18e-06 | 2 | 43 | 2 | IPR016569 | |
| Domain | DUF902 | 5.18e-06 | 2 | 43 | 2 | PF06001 | |
| Domain | - | 5.18e-06 | 2 | 43 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 5.18e-06 | 2 | 43 | 2 | IPR010303 | |
| Domain | KAT11 | 5.18e-06 | 2 | 43 | 2 | SM01250 | |
| Domain | - | 5.18e-06 | 2 | 43 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 5.18e-06 | 2 | 43 | 2 | IPR000197 | |
| Domain | KIX_dom | 5.18e-06 | 2 | 43 | 2 | IPR003101 | |
| Domain | Creb_binding | 5.18e-06 | 2 | 43 | 2 | PF09030 | |
| Domain | KIX | 5.18e-06 | 2 | 43 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 5.18e-06 | 2 | 43 | 2 | PS51727 | |
| Domain | Post-SET_dom | 6.23e-06 | 16 | 43 | 3 | IPR003616 | |
| Domain | PostSET | 6.23e-06 | 16 | 43 | 3 | SM00508 | |
| Domain | POST_SET | 6.23e-06 | 16 | 43 | 3 | PS50868 | |
| Domain | EPHD | 1.70e-05 | 22 | 43 | 3 | PS51805 | |
| Domain | AT_hook | 3.20e-05 | 27 | 43 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 3.20e-05 | 27 | 43 | 3 | IPR017956 | |
| Domain | VWFC_1 | 7.70e-05 | 36 | 43 | 3 | PS01208 | |
| Domain | Nuc_rcpt_coact | 7.72e-05 | 6 | 43 | 2 | IPR009110 | |
| Domain | BROMODOMAIN_2 | 1.14e-04 | 41 | 43 | 3 | PS50014 | |
| Domain | SET | 1.14e-04 | 41 | 43 | 3 | PF00856 | |
| Domain | BROMO | 1.23e-04 | 42 | 43 | 3 | SM00297 | |
| Domain | Bromodomain | 1.23e-04 | 42 | 43 | 3 | IPR001487 | |
| Domain | - | 1.23e-04 | 42 | 43 | 3 | 1.20.920.10 | |
| Domain | SET | 1.61e-04 | 46 | 43 | 3 | SM00317 | |
| Domain | SET_dom | 2.07e-04 | 50 | 43 | 3 | IPR001214 | |
| Domain | SET | 2.07e-04 | 50 | 43 | 3 | PS50280 | |
| Domain | zf-CXXC | 2.81e-04 | 11 | 43 | 2 | PF02008 | |
| Domain | Znf_CXXC | 2.81e-04 | 11 | 43 | 2 | IPR002857 | |
| Domain | ZF_CXXC | 2.81e-04 | 11 | 43 | 2 | PS51058 | |
| Domain | ZnF_GATA | 3.37e-04 | 12 | 43 | 2 | SM00401 | |
| Domain | Ras_G-nucl-exch_fac_CS | 4.63e-04 | 14 | 43 | 2 | IPR019804 | |
| Domain | Glyco_hormone_CN | 5.33e-04 | 15 | 43 | 2 | IPR006208 | |
| Domain | Cys_knot | 5.33e-04 | 15 | 43 | 2 | PF00007 | |
| Domain | Znf_GATA | 5.33e-04 | 15 | 43 | 2 | IPR000679 | |
| Domain | GATA | 5.33e-04 | 15 | 43 | 2 | PF00320 | |
| Domain | GATA_ZN_FINGER_1 | 6.09e-04 | 16 | 43 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 6.09e-04 | 16 | 43 | 2 | PS50114 | |
| Domain | PHD | 6.84e-04 | 75 | 43 | 3 | PF00628 | |
| Domain | ZF_ZZ_2 | 7.74e-04 | 18 | 43 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 7.74e-04 | 18 | 43 | 2 | PS01357 | |
| Domain | ZZ | 7.74e-04 | 18 | 43 | 2 | PF00569 | |
| Domain | Znf_PHD-finger | 7.96e-04 | 79 | 43 | 3 | IPR019787 | |
| Domain | Znf_ZZ | 8.64e-04 | 19 | 43 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 8.64e-04 | 19 | 43 | 2 | SM00291 | |
| Domain | RasGEFN | 9.58e-04 | 20 | 43 | 2 | SM00229 | |
| Domain | RasGEF_N | 1.06e-03 | 21 | 43 | 2 | PF00618 | |
| Domain | PHD | 1.12e-03 | 89 | 43 | 3 | SM00249 | |
| Domain | RASGEF_NTER | 1.16e-03 | 22 | 43 | 2 | PS50212 | |
| Domain | Ras-like_Gua-exchang_fac_N | 1.16e-03 | 22 | 43 | 2 | IPR000651 | |
| Domain | Znf_PHD | 1.20e-03 | 91 | 43 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.36e-03 | 95 | 43 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.40e-03 | 96 | 43 | 3 | PS01359 | |
| Domain | RASGEF | 1.62e-03 | 26 | 43 | 2 | PS00720 | |
| Domain | Bromodomain_CS | 1.62e-03 | 26 | 43 | 2 | IPR018359 | |
| Domain | VWC | 1.88e-03 | 28 | 43 | 2 | PF00093 | |
| Domain | RASGEF_CAT | 2.02e-03 | 29 | 43 | 2 | PS50009 | |
| Domain | RasGEF | 2.16e-03 | 30 | 43 | 2 | PF00617 | |
| Domain | - | 2.16e-03 | 30 | 43 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 2.16e-03 | 30 | 43 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 2.16e-03 | 30 | 43 | 2 | IPR001895 | |
| Domain | RasGEF | 2.16e-03 | 30 | 43 | 2 | SM00147 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.86e-09 | 21 | 37 | 5 | MM15706 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 9.48e-08 | 44 | 37 | 5 | MM15527 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.63e-07 | 60 | 37 | 5 | MM15636 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 4.84e-06 | 96 | 37 | 5 | M27792 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.02e-06 | 109 | 37 | 5 | MM15164 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 9.10e-06 | 16 | 37 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.10e-05 | 17 | 37 | 3 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.84e-05 | 23 | 37 | 3 | M556 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 3.04e-05 | 140 | 37 | 5 | M27484 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 3.18e-05 | 237 | 37 | 6 | M27786 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 4.15e-05 | 26 | 37 | 3 | M27483 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 4.65e-05 | 153 | 37 | 5 | MM15522 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 6.67e-05 | 5 | 37 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 6.67e-05 | 5 | 37 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 6.67e-05 | 5 | 37 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 6.67e-05 | 5 | 37 | 2 | M48023 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 9.99e-05 | 6 | 37 | 2 | M22062 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.32e-04 | 38 | 37 | 3 | MM17073 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.40e-04 | 7 | 37 | 2 | MM1573 | |
| Pathway | PID_IFNG_PATHWAY | 1.54e-04 | 40 | 37 | 3 | M161 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.78e-04 | 42 | 37 | 3 | M48018 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.86e-04 | 8 | 37 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.86e-04 | 8 | 37 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.86e-04 | 8 | 37 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.86e-04 | 8 | 37 | 2 | M46443 | |
| Pathway | PID_HNF3A_PATHWAY | 2.05e-04 | 44 | 37 | 3 | M285 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 2.34e-04 | 46 | 37 | 3 | MM14933 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 2.39e-04 | 9 | 37 | 2 | M47451 | |
| Pathway | PID_HES_HEY_PATHWAY | 2.65e-04 | 48 | 37 | 3 | M288 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 2.98e-04 | 10 | 37 | 2 | M27945 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 3.63e-04 | 11 | 37 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 3.63e-04 | 11 | 37 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 3.63e-04 | 11 | 37 | 2 | M26924 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 4.28e-04 | 136 | 37 | 4 | MM14848 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 4.35e-04 | 12 | 37 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 4.35e-04 | 12 | 37 | 2 | M27765 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.66e-04 | 62 | 37 | 3 | M546 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 5.98e-04 | 14 | 37 | 2 | M27808 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 6.50e-04 | 65 | 37 | 3 | M39374 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 6.50e-04 | 65 | 37 | 3 | M39682 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 6.78e-04 | 272 | 37 | 5 | M29619 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 6.80e-04 | 66 | 37 | 3 | M101 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 6.89e-04 | 15 | 37 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 6.89e-04 | 15 | 37 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 6.89e-04 | 15 | 37 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 6.89e-04 | 15 | 37 | 2 | M953 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 7.42e-04 | 68 | 37 | 3 | M27303 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 7.74e-04 | 69 | 37 | 3 | M48052 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 7.86e-04 | 16 | 37 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 7.86e-04 | 16 | 37 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 7.86e-04 | 16 | 37 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 7.86e-04 | 16 | 37 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 7.86e-04 | 16 | 37 | 2 | M27940 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 8.07e-04 | 70 | 37 | 3 | M27231 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 8.89e-04 | 17 | 37 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 8.89e-04 | 17 | 37 | 2 | M48025 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 9.99e-04 | 18 | 37 | 2 | M26942 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.11e-03 | 19 | 37 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 1.11e-03 | 19 | 37 | 2 | M46442 | |
| Pathway | PID_MYC_ACTIV_PATHWAY | 1.15e-03 | 79 | 37 | 3 | M66 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.24e-03 | 20 | 37 | 2 | M27881 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 1.36e-03 | 21 | 37 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.36e-03 | 21 | 37 | 2 | M27485 | |
| Pathway | PID_CMYB_PATHWAY | 1.37e-03 | 84 | 37 | 3 | M195 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.50e-03 | 22 | 37 | 2 | MM1443 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.50e-03 | 22 | 37 | 2 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.64e-03 | 23 | 37 | 2 | M2821 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.73e-03 | 91 | 37 | 3 | M27101 | |
| Pathway | WP_ANGIOGENESIS | 1.78e-03 | 24 | 37 | 2 | M39556 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.78e-03 | 24 | 37 | 2 | M13404 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.94e-03 | 25 | 37 | 2 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 2.09e-03 | 26 | 37 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 2.09e-03 | 26 | 37 | 2 | M32 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.09e-03 | 26 | 37 | 2 | MM14793 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 2.43e-03 | 28 | 37 | 2 | M27254 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.55e-03 | 220 | 37 | 4 | M27794 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.78e-03 | 30 | 37 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 2.78e-03 | 30 | 37 | 2 | M936 | |
| Pathway | WP_SPINAL_CORD_INJURY | 2.81e-03 | 108 | 37 | 3 | MM15954 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.04e-03 | 111 | 37 | 3 | M27416 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 3.16e-03 | 32 | 37 | 2 | M39521 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 3.44e-03 | 116 | 37 | 3 | MM15715 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 3.57e-03 | 34 | 37 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 3.57e-03 | 34 | 37 | 2 | M44 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 3.78e-03 | 35 | 37 | 2 | M48246 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 3.96e-03 | 122 | 37 | 3 | M29689 | |
| Pathway | PID_FRA_PATHWAY | 4.21e-03 | 37 | 37 | 2 | M65 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 4.26e-03 | 254 | 37 | 4 | M27131 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 4.44e-03 | 38 | 37 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 4.44e-03 | 38 | 37 | 2 | M27255 | |
| Pathway | REACTOME_GASTRULATION | 4.64e-03 | 129 | 37 | 3 | M46433 | |
| Pathway | PID_FOXM1_PATHWAY | 4.91e-03 | 40 | 37 | 2 | M176 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 5.05e-03 | 133 | 37 | 3 | MM15529 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 5.40e-03 | 42 | 37 | 2 | M17541 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 5.48e-03 | 137 | 37 | 3 | M145 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 5.92e-03 | 44 | 37 | 2 | M27295 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 6.17e-03 | 143 | 37 | 3 | M27275 | |
| Pathway | WP_MALE_INFERTILITY | 6.41e-03 | 145 | 37 | 3 | M39856 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 6.73e-03 | 47 | 37 | 2 | M7946 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 6.91e-03 | 149 | 37 | 3 | M27888 | |
| Pubmed | 1.36e-14 | 6 | 43 | 5 | 19110483 | ||
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 17471237 | ||
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 2.02e-12 | 4 | 43 | 4 | 29869461 | |
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 23807779 | ||
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 12676567 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.92e-11 | 18 | 43 | 5 | 18834073 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 18825309 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 18300795 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 10347196 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 19718741 | ||
| Pubmed | Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300. | 7.04e-09 | 4 | 43 | 3 | 17707401 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 28398509 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 11581372 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 33154304 | ||
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 7.04e-09 | 4 | 43 | 3 | 24901817 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 25638393 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 36367122 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 7.04e-09 | 4 | 43 | 3 | 22269464 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 22207202 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 7.04e-09 | 4 | 43 | 3 | 23129768 | |
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 7.04e-09 | 4 | 43 | 3 | 20929551 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 21596555 | ||
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 7.04e-09 | 4 | 43 | 3 | 27298226 | |
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 7.04e-09 | 4 | 43 | 3 | 17401217 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 25298197 | ||
| Pubmed | 9.07e-09 | 57 | 43 | 5 | 18022353 | ||
| Pubmed | KMT2A RPRD2 KMT2D MIDN RERE KMT2B SRCAP FOXA1 CREBBP CAPRIN1 EP300 SYMPK GATA1 | 1.04e-08 | 1429 | 43 | 13 | 35140242 | |
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 26320581 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 1.76e-08 | 5 | 43 | 3 | 11062147 | |
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 24840470 | ||
| Pubmed | MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia. | 1.76e-08 | 5 | 43 | 3 | 28609655 | |
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 22261707 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 1.76e-08 | 5 | 43 | 3 | 16188033 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 1.76e-08 | 5 | 43 | 3 | 16475027 | |
| Pubmed | Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs. | 3.51e-08 | 6 | 43 | 3 | 24176642 | |
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 17982272 | ||
| Pubmed | MLL associates specifically with a subset of transcriptionally active target genes. | 3.51e-08 | 6 | 43 | 3 | 16199523 | |
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 19219072 | ||
| Pubmed | A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. | 6.14e-08 | 7 | 43 | 3 | 18316626 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LPIN3 MAP3K11 KMT2D KMT2B SRCAP PRAG1 RGL2 KIF26A EP300 SYMPK ATPAF2 | 7.17e-08 | 1105 | 43 | 11 | 35748872 |
| Pubmed | The mutational landscape of lethal castration-resistant prostate cancer. | 9.82e-08 | 8 | 43 | 3 | 22722839 | |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 9.82e-08 | 8 | 43 | 3 | 23130995 | |
| Pubmed | 9.82e-08 | 8 | 43 | 3 | 22266653 | ||
| Pubmed | 1.30e-07 | 486 | 43 | 8 | 20936779 | ||
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 22665483 | ||
| Pubmed | Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression. | 1.47e-07 | 9 | 43 | 3 | 16951254 | |
| Pubmed | 2.10e-07 | 10 | 43 | 3 | 25223786 | ||
| Pubmed | 2.41e-07 | 43 | 43 | 4 | 33472061 | ||
| Pubmed | Tracing colonic embryonic transcriptional profiles and their reactivation upon intestinal damage. | 2.88e-07 | 11 | 43 | 3 | 34348153 | |
| Pubmed | 3.27e-07 | 549 | 43 | 8 | 38280479 | ||
| Pubmed | Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. | 3.84e-07 | 12 | 43 | 3 | 17707229 | |
| Pubmed | 3.84e-07 | 12 | 43 | 3 | 27563068 | ||
| Pubmed | 9.50e-07 | 268 | 43 | 6 | 33640491 | ||
| Pubmed | 9.75e-07 | 16 | 43 | 3 | 23870121 | ||
| Pubmed | Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. | 9.75e-07 | 16 | 43 | 3 | 22780989 | |
| Pubmed | 1.18e-06 | 17 | 43 | 3 | 19183483 | ||
| Pubmed | 1.47e-06 | 157 | 43 | 5 | 30186101 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 27881875 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 7513696 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 17203232 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 25704757 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.49e-06 | 2 | 43 | 2 | 34845315 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 34058148 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 37146737 | ||
| Pubmed | KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. | 1.49e-06 | 2 | 43 | 2 | 28723559 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 19729597 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 1.49e-06 | 2 | 43 | 2 | 14988081 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 15860545 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 29460469 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 17484881 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 15563276 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 1.49e-06 | 2 | 43 | 2 | 24551300 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 17621824 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24317696 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 33911074 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 9018065 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 22391959 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24648406 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 14718370 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 30135524 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 1.49e-06 | 2 | 43 | 2 | 35776514 | |
| Pubmed | Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. | 1.49e-06 | 2 | 43 | 2 | 12527922 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 1.49e-06 | 2 | 43 | 2 | 16596650 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24327612 | ||
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 1.49e-06 | 2 | 43 | 2 | 29217654 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 12205094 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 1.49e-06 | 2 | 43 | 2 | 21653907 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 28321513 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 20717166 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 9422745 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 10049825 | ||
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 1.49e-06 | 2 | 43 | 2 | 36427316 | |
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 1.49e-06 | 2 | 43 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 1.49e-06 | 2 | 43 | 2 | 29170789 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 25893291 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 11559821 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 21555743 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 35640156 | ||
| Interaction | NCOA6 interactions | 2.24e-08 | 145 | 43 | 7 | int:NCOA6 | |
| Interaction | SMARCC2 interactions | 4.68e-08 | 353 | 43 | 9 | int:SMARCC2 | |
| Interaction | KDM6A interactions | 4.81e-08 | 162 | 43 | 7 | int:KDM6A | |
| Interaction | ASH2L interactions | 1.35e-06 | 265 | 43 | 7 | int:ASH2L | |
| Interaction | KMT2D interactions | 1.50e-06 | 169 | 43 | 6 | int:KMT2D | |
| Interaction | SETD1A interactions | 1.55e-06 | 170 | 43 | 6 | int:SETD1A | |
| Interaction | TFF1 interactions | 1.72e-06 | 41 | 43 | 4 | int:TFF1 | |
| Interaction | RBBP5 interactions | 2.29e-06 | 287 | 43 | 7 | int:RBBP5 | |
| Interaction | RBBP4 interactions | 2.71e-06 | 573 | 43 | 9 | int:RBBP4 | |
| Interaction | DEK interactions | 5.13e-06 | 209 | 43 | 6 | int:DEK | |
| Interaction | TOP3B interactions | LPIN3 MAP3K11 KMT2D KMT2B SRCAP PRAG1 RGL2 KIF26A CAPRIN1 EP300 CPEB4 SYMPK ATPAF2 | 7.23e-06 | 1470 | 43 | 13 | int:TOP3B |
| Interaction | CXXC1 interactions | 8.81e-06 | 132 | 43 | 5 | int:CXXC1 | |
| Interaction | MYB interactions | 9.14e-06 | 133 | 43 | 5 | int:MYB | |
| Interaction | SPIB interactions | 1.01e-05 | 20 | 43 | 3 | int:SPIB | |
| Interaction | SMARCB1 interactions | 1.09e-05 | 364 | 43 | 7 | int:SMARCB1 | |
| Interaction | TLE3 interactions | 1.34e-05 | 376 | 43 | 7 | int:TLE3 | |
| Interaction | HDAC1 interactions | KMT2A KMT2D CDK2AP2 RERE KMT2B CREBBP CAPRIN1 EP300 PPP4R3A SYMPK GATA1 | 1.49e-05 | 1108 | 43 | 11 | int:HDAC1 |
| Interaction | SMARCC1 interactions | 1.54e-05 | 384 | 43 | 7 | int:SMARCC1 | |
| Interaction | SETD1B interactions | 1.96e-05 | 75 | 43 | 4 | int:SETD1B | |
| Interaction | H3C14 interactions | 1.98e-05 | 156 | 43 | 5 | int:H3C14 | |
| Interaction | HNF4A interactions | 2.44e-05 | 275 | 43 | 6 | int:HNF4A | |
| Interaction | EGR2 interactions | 3.08e-05 | 171 | 43 | 5 | int:EGR2 | |
| Interaction | GSC interactions | 3.52e-05 | 87 | 43 | 4 | int:GSC | |
| Interaction | SP7 interactions | 4.27e-05 | 304 | 43 | 6 | int:SP7 | |
| Interaction | HCFC2 interactions | 4.38e-05 | 92 | 43 | 4 | int:HCFC2 | |
| Interaction | FOXI1 interactions | 4.38e-05 | 92 | 43 | 4 | int:FOXI1 | |
| Interaction | RERE interactions | 4.57e-05 | 93 | 43 | 4 | int:RERE | |
| Interaction | SIRT6 interactions | 4.70e-05 | 628 | 43 | 8 | int:SIRT6 | |
| Interaction | KMT2A interactions | 5.12e-05 | 314 | 43 | 6 | int:KMT2A | |
| Interaction | E2F5 interactions | 6.15e-05 | 36 | 43 | 3 | int:E2F5 | |
| Interaction | HOXB2 interactions | 6.15e-05 | 36 | 43 | 3 | int:HOXB2 | |
| Interaction | RCC1 interactions | 6.64e-05 | 201 | 43 | 5 | int:RCC1 | |
| Interaction | KLF1 interactions | 6.68e-05 | 37 | 43 | 3 | int:KLF1 | |
| Interaction | FEV interactions | 6.96e-05 | 203 | 43 | 5 | int:FEV | |
| Interaction | DPY30 interactions | 7.12e-05 | 204 | 43 | 5 | int:DPY30 | |
| Interaction | HDAC2 interactions | 7.18e-05 | 865 | 43 | 9 | int:HDAC2 | |
| Interaction | PSIP1 interactions | 7.29e-05 | 205 | 43 | 5 | int:PSIP1 | |
| Interaction | WDR5 interactions | KMT2A MARCKSL1 KMT2D RERE KMT2B FOXA1 CREBBP CAPRIN1 EP300 SYMPK | 8.35e-05 | 1101 | 43 | 10 | int:WDR5 |
| Interaction | WDR82 interactions | 8.74e-05 | 213 | 43 | 5 | int:WDR82 | |
| Interaction | SMARCA2 interactions | 8.75e-05 | 346 | 43 | 6 | int:SMARCA2 | |
| Interaction | RBBP7 interactions | 8.99e-05 | 507 | 43 | 7 | int:RBBP7 | |
| Interaction | NUCKS1 interactions | 1.02e-04 | 220 | 43 | 5 | int:NUCKS1 | |
| Interaction | PAXIP1 interactions | 1.07e-04 | 359 | 43 | 6 | int:PAXIP1 | |
| Interaction | NFIX interactions | 1.18e-04 | 227 | 43 | 5 | int:NFIX | |
| Interaction | ETS1 interactions | 1.27e-04 | 121 | 43 | 4 | int:ETS1 | |
| Interaction | BUB3 interactions | 1.30e-04 | 232 | 43 | 5 | int:BUB3 | |
| Interaction | FOSB interactions | 1.56e-04 | 49 | 43 | 3 | int:FOSB | |
| Interaction | HOXB3 interactions | 1.59e-04 | 9 | 43 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 1.59e-04 | 9 | 43 | 2 | int:ARGFX | |
| Interaction | KMT2B interactions | 1.68e-04 | 130 | 43 | 4 | int:KMT2B | |
| Interaction | ASF1A interactions | 1.81e-04 | 249 | 43 | 5 | int:ASF1A | |
| Interaction | HES6 interactions | 1.86e-04 | 52 | 43 | 3 | int:HES6 | |
| Interaction | KMT2C interactions | 1.89e-04 | 134 | 43 | 4 | int:KMT2C | |
| Interaction | PHF20 interactions | 1.97e-04 | 53 | 43 | 3 | int:PHF20 | |
| Interaction | ONECUT1 interactions | 1.98e-04 | 10 | 43 | 2 | int:ONECUT1 | |
| Interaction | AR interactions | 2.03e-04 | 992 | 43 | 9 | int:AR | |
| Interaction | ZZZ3 interactions | 2.17e-04 | 139 | 43 | 4 | int:ZZZ3 | |
| Interaction | E2F2 interactions | 2.20e-04 | 55 | 43 | 3 | int:E2F2 | |
| Interaction | TADA3 interactions | 2.29e-04 | 141 | 43 | 4 | int:TADA3 | |
| Interaction | LDB2 interactions | 2.32e-04 | 56 | 43 | 3 | int:LDB2 | |
| Interaction | WWTR1 interactions | 2.57e-04 | 422 | 43 | 6 | int:WWTR1 | |
| Interaction | MTA2 interactions | 3.03e-04 | 435 | 43 | 6 | int:MTA2 | |
| Interaction | HOXA10 interactions | 3.13e-04 | 62 | 43 | 3 | int:HOXA10 | |
| Interaction | SPI1 interactions | 3.94e-04 | 67 | 43 | 3 | int:SPI1 | |
| Interaction | FUBP3 interactions | 4.09e-04 | 297 | 43 | 5 | int:FUBP3 | |
| Interaction | GCM1 interactions | 4.12e-04 | 68 | 43 | 3 | int:GCM1 | |
| Interaction | MBIP interactions | 4.17e-04 | 165 | 43 | 4 | int:MBIP | |
| Interaction | YAP1 interactions | 4.22e-04 | 1095 | 43 | 9 | int:YAP1 | |
| Interaction | ETV4 interactions | 4.30e-04 | 69 | 43 | 3 | int:ETV4 | |
| Interaction | BMI1 interactions | 4.48e-04 | 659 | 43 | 7 | int:BMI1 | |
| Interaction | KANSL2 interactions | 4.48e-04 | 70 | 43 | 3 | int:KANSL2 | |
| Interaction | KLF2 interactions | 4.59e-04 | 15 | 43 | 2 | int:KLF2 | |
| Interaction | GATA1 interactions | 4.77e-04 | 171 | 43 | 4 | int:GATA1 | |
| Interaction | EGR1 interactions | 4.87e-04 | 72 | 43 | 3 | int:EGR1 | |
| Interaction | AREG interactions | 5.24e-04 | 16 | 43 | 2 | int:AREG | |
| Interaction | PHF20L1 interactions | 5.49e-04 | 75 | 43 | 3 | int:PHF20L1 | |
| Interaction | GPBP1 interactions | 5.49e-04 | 75 | 43 | 3 | int:GPBP1 | |
| Interaction | SMG7 interactions | 5.66e-04 | 319 | 43 | 5 | int:SMG7 | |
| Interaction | KISS1 interactions | 5.93e-04 | 17 | 43 | 2 | int:KISS1 | |
| Interaction | EBF1 interactions | 5.93e-04 | 17 | 43 | 2 | int:EBF1 | |
| Interaction | MAML2 interactions | 5.93e-04 | 17 | 43 | 2 | int:MAML2 | |
| Interaction | TACC2 interactions | 5.93e-04 | 77 | 43 | 3 | int:TACC2 | |
| Interaction | ALG13 interactions | 6.16e-04 | 183 | 43 | 4 | int:ALG13 | |
| Interaction | KLF8 interactions | 6.51e-04 | 329 | 43 | 5 | int:KLF8 | |
| Interaction | HNF1A interactions | 6.63e-04 | 80 | 43 | 3 | int:HNF1A | |
| Interaction | NADK interactions | 6.63e-04 | 80 | 43 | 3 | int:NADK | |
| Interaction | GATA3 interactions | 6.68e-04 | 187 | 43 | 4 | int:GATA3 | |
| Interaction | ATN1 interactions | 6.68e-04 | 187 | 43 | 4 | int:ATN1 | |
| Interaction | NFIA interactions | 6.81e-04 | 188 | 43 | 4 | int:NFIA | |
| Interaction | PML interactions | 7.01e-04 | 933 | 43 | 8 | int:PML | |
| Interaction | SOX7 interactions | 7.13e-04 | 82 | 43 | 3 | int:SOX7 | |
| Interaction | NEUROG1 interactions | 7.43e-04 | 19 | 43 | 2 | int:NEUROG1 | |
| Interaction | DBP interactions | 7.43e-04 | 19 | 43 | 2 | int:DBP | |
| Interaction | RPTOR interactions | 7.65e-04 | 341 | 43 | 5 | int:RPTOR | |
| Interaction | KANSL3 interactions | 8.19e-04 | 86 | 43 | 3 | int:KANSL3 | |
| Interaction | CPSF6 interactions | 8.25e-04 | 526 | 43 | 6 | int:CPSF6 | |
| Interaction | POLR1E interactions | 8.60e-04 | 350 | 43 | 5 | int:POLR1E | |
| Interaction | PPP1CC interactions | 8.76e-04 | 738 | 43 | 7 | int:PPP1CC | |
| Interaction | MED17 interactions | 8.90e-04 | 202 | 43 | 4 | int:MED17 | |
| Interaction | POLR2A interactions | 9.09e-04 | 536 | 43 | 6 | int:POLR2A | |
| Cytoband | 11p15.5 | 9.17e-08 | 118 | 43 | 5 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.80e-04 | 564 | 43 | 5 | chr11p15 | |
| Cytoband | 19q13.4 | 2.52e-03 | 79 | 43 | 2 | 19q13.4 | |
| GeneFamily | CD molecules|Mucins | 1.22e-10 | 21 | 28 | 5 | 648 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.93e-05 | 34 | 28 | 3 | 487 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 2.31e-05 | 5 | 28 | 2 | 1182 | |
| GeneFamily | Zinc fingers CXXC-type | 1.51e-04 | 12 | 28 | 2 | 136 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.40e-04 | 15 | 28 | 2 | 82 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.10e-04 | 17 | 28 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.48e-04 | 18 | 28 | 2 | 91 | |
| GeneFamily | PHD finger proteins | 3.57e-04 | 90 | 28 | 3 | 88 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.30e-03 | 46 | 28 | 2 | 622 | |
| Coexpression | NABA_ECM_AFFILIATED | 5.98e-06 | 158 | 43 | 5 | MM17063 | |
| Coexpression | NABA_ECM_AFFILIATED | 8.53e-06 | 170 | 43 | 5 | M5880 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN | 1.74e-05 | 197 | 43 | 5 | M5877 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.59e-07 | 177 | 43 | 5 | b647667da62a91dbe3890820142626e26aa779d2 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-07 | 177 | 43 | 5 | 709235694cc711b9b79690e23c94577b2ae06811 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-07 | 177 | 43 | 5 | 7f9c2a45a994b32f15e5693f7cb873716a4eb568 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.71e-07 | 182 | 43 | 5 | dc29e8735c3562ce32322351d28f7d9709208ebf | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.07e-05 | 142 | 43 | 4 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-05 | 143 | 43 | 4 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 149 | 43 | 4 | 2a2a5673ce4f376e7b25f2bc8127fb7e260f37af | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 149 | 43 | 4 | c9f02ec62a658a751e591699f9395fe597e22a2e | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 159 | 43 | 4 | baf843dc44b072504eb1d28de55b1ee67aeec32b | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 159 | 43 | 4 | 9eb78202b9a4e8217f00e64d5142ed28c00abd04 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-05 | 162 | 43 | 4 | 4e7e565091bce227d794a36af2e5dfc4a791efad | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-05 | 162 | 43 | 4 | ad974426039f4952c59d27167eac24dc6ce63f5e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-05 | 166 | 43 | 4 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-05 | 166 | 43 | 4 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-05 | 166 | 43 | 4 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-05 | 169 | 43 | 4 | a54a8494c1feff29d77ab4737fcfabc84ace5c94 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.21e-05 | 171 | 43 | 4 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 172 | 43 | 4 | c0bda7153e02bee7d0326138cc684151c404c2a1 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.71e-05 | 180 | 43 | 4 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | Control-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 2.89e-05 | 183 | 43 | 4 | bdd461349a1ef43a015843937d26e8d3571ecc22 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.08e-05 | 186 | 43 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Neutrophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.34e-05 | 190 | 43 | 4 | 5da4a90f56f66567614d84b9b437f559006ea51c | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 3.48e-05 | 192 | 43 | 4 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | C_06|World / shred on cell type and cluster | 3.63e-05 | 194 | 43 | 4 | 5cb42e09f380c4468cdc603ec0c3de35eadd3213 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.77e-05 | 196 | 43 | 4 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 3.77e-05 | 196 | 43 | 4 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | mild-Myeloid-Neutrophils_4|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.77e-05 | 196 | 43 | 4 | f8c98cded5550843322b1711e1a57c7e88cae861 | |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | 3.93e-05 | 198 | 43 | 4 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.93e-05 | 198 | 43 | 4 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | proximal-Epithelial-Mucous-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | baac580484124b7c36717b607adcf2cb446e631d | |
| ToppCell | proximal-Epithelial-Mucous|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 15ba36fa6ad73d0e959e42f18d7acbc14e310dc9 | |
| ToppCell | severe-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.00e-05 | 199 | 43 | 4 | 50242666def13e5d4149c563ae000d6768f086f7 | |
| ToppCell | proximal-3-Epithelial-Mucous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 3018378860de084662be0cc46fce421db3bb9ec9 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 700960201ae0df2c79e2907f5a0f95d73f8034fe | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 3cfb28299a55fc1c150262a7333c59a48ae65ad1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.08e-05 | 200 | 43 | 4 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.08e-05 | 200 | 43 | 4 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | severe-Myeloid-Neutrophils_4|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.08e-05 | 200 | 43 | 4 | b665f36dcf3c9d3981ee96f2973512f751612542 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | a1ae299cf77580a6d1a728ee591888b6d70a19d6 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 1438b84096de9b4abe9e6213caa07f6bdff67358 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.94e-05 | 93 | 43 | 3 | 93a8d3ad978e4cd450f7a69a4cbac1a59038e80d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.51e-04 | 107 | 43 | 3 | d694e72244d0b79be7e47c393c06aa55d504aba8 | |
| ToppCell | control-Myeloid-Monocyte-derived_DC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.55e-04 | 108 | 43 | 3 | e74e73d89d78c8d59dfdd2bd30db54b366a49d23 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.38e-04 | 125 | 43 | 3 | b82ce58b6262b0739c788395766e5fc77d2744f2 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.12e-04 | 137 | 43 | 3 | 291b4eeaf21ec951695621161dbc2de3e82ca993 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.32e-04 | 140 | 43 | 3 | 90298cac4bcec614a48e60b5c139c86daa9f0321 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.32e-04 | 140 | 43 | 3 | 671ab1f5cbd8568bf93ebdf961c2a1ede06d2bcb | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.61e-04 | 144 | 43 | 3 | c0c5f254a960ba5e5f1354599d54e77360e6c2ac | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.61e-04 | 144 | 43 | 3 | 1efa434e577d1f87e02df01667782f414d63bd60 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-04 | 145 | 43 | 3 | ab0e254a8d01021619853a6c175f620ccef217d8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-04 | 145 | 43 | 3 | 2beb4ea3838796c580076ab7769de877a3a0552c | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.91e-04 | 148 | 43 | 3 | 74f1f9d1a53dc1a09cb6a504cbbdc7496c5b6879 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-04 | 148 | 43 | 3 | 6cd7ef4f29d9a0944f724d9d8117d4d25e517fe4 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-04 | 149 | 43 | 3 | 4de52569611e63a780cde9bd111d6d9c11a05a11 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-04 | 149 | 43 | 3 | c957ac23ad6343eacce7e6be4a6d3ac043af4f86 | |
| ToppCell | Myeloid-Myeloid-E_(Neutrophils)|Myeloid / shred on cell class and cell subclass (v4) | 4.06e-04 | 150 | 43 | 3 | 1bffb8d86b737ac43be902d9468041aef3542f1f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Lepidic_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.14e-04 | 151 | 43 | 3 | 3dfa1d89975ffaa45b26833538244153d50c60a7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-04 | 151 | 43 | 3 | 10da94037225a71844281ddcb395072250a78094 | |
| ToppCell | facs-Trachea-nan-24m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-04 | 151 | 43 | 3 | 26fd55efb647c41436416d45952ee97b050e632c | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Lepidic_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.14e-04 | 151 | 43 | 3 | 60bb6de5d9b13402bc18cb6d5e51078326dff8e2 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-04 | 153 | 43 | 3 | 6a2a2379238133ce0ad714af130ffe02dd317247 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-04 | 153 | 43 | 3 | faa442dd925b2b09919e93c492ccc3f19803ad24 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l8|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.31e-04 | 153 | 43 | 3 | 338684d420b01e32918fa19048ccdda234942ce1 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-04 | 155 | 43 | 3 | 3f31f3c37eb40d5467def8506e349fa4b4695833 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 4.56e-04 | 156 | 43 | 3 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l8|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.64e-04 | 157 | 43 | 3 | 5098675f64342c41c5ca3551b24962d10c83e64d | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 157 | 43 | 3 | c8f516d3f5622202d3f8514f68614cd86ea3f667 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 157 | 43 | 3 | 4862a11ab8df27d26b4f1c1785e544a2d5b6db6e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 157 | 43 | 3 | a0ec1628ce29841889f1d9d4ee9422921af7b0b5 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.64e-04 | 157 | 43 | 3 | 188d2f85babcd4eefe20e7a392d851b2e1185bab | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 158 | 43 | 3 | 30cceb73cf5e24b692da84d33342fd3b1ad5efe5 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 158 | 43 | 3 | 47793463640f98ee5f680a1ee5786b453355fd57 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.82e-04 | 159 | 43 | 3 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-neutrophil-neutrophil|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.82e-04 | 159 | 43 | 3 | be54b910ccb73e37eb81945bbad9a89d2bcec34b | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.82e-04 | 159 | 43 | 3 | 75a82bbabd97b168dbf1c3f43a9bdad48ce18c78 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-neutrophil|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.82e-04 | 159 | 43 | 3 | 178678173b005cb8225472306657f0d8289b133b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.91e-04 | 160 | 43 | 3 | 6de505bfe1fbbe984718740a9cf43d0e02ff452e | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 160 | 43 | 3 | bd5fa7959bfe81011b8d798535b73ea1eee008b3 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 161 | 43 | 3 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 161 | 43 | 3 | 65888250b8c1da6a8f9b5376e086a3769a1cbbd8 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.09e-04 | 162 | 43 | 3 | fe546c2272a70bb5f08e6e097b9accdb891eda23 | |
| ToppCell | droplet-Fat-Gat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 162 | 43 | 3 | 052f797d8bcab8fc6a43e0bffdd215c88ee12889 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.09e-04 | 162 | 43 | 3 | 2f19539c455d1e5d514725845234c7547020e6ad | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 163 | 43 | 3 | 5fc836444bc156c8248abee001b0ecbe43f980c9 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.18e-04 | 163 | 43 | 3 | 240d9f0ea45e8b2c7173e7674fd740555810f9e7 | |
| ToppCell | facs-Heart-RA-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 163 | 43 | 3 | da7ab9582e8070b07ca628a6394c86684d37d6ef | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 164 | 43 | 3 | baf6c40b004433c6b1d0bbbb74f73fcd6ee162ea | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.27e-04 | 164 | 43 | 3 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.27e-04 | 164 | 43 | 3 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.27e-04 | 164 | 43 | 3 | 3c15e9b8403b03d67f6ecd7861dc19f1261e3244 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.27e-04 | 164 | 43 | 3 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.27e-04 | 164 | 43 | 3 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 164 | 43 | 3 | 1fc64b21e97e651f88a92de51536b3753f3e08d6 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-04 | 165 | 43 | 3 | 1d844d19ff9b49dd0f61f0b24799e172076771ef | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-04 | 165 | 43 | 3 | fe2135fdacf3807eb4b5ea5e790febfb8cd54335 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-04 | 165 | 43 | 3 | 47e716ce8dc283d406352c1909e09362fcb9e3a3 | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-04 | 165 | 43 | 3 | 35a6de30438de364ccca948fc932da541a69ef89 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-04 | 165 | 43 | 3 | 9a6abd0e6b11860231ce5e845c87b8d66f3ef697 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-04 | 165 | 43 | 3 | 9d2bdc42c13c8c2a68889bec8612a1ce56f659fa | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-04 | 165 | 43 | 3 | 433771abefc5bcb89bdae64af45cce7407bffe5d | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; PC3; HT_HG-U133A | 1.52e-06 | 191 | 43 | 6 | 4614_UP | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 2.68e-08 | 5 | 42 | 3 | DOID:3030 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 3.27e-08 | 64 | 42 | 5 | DOID:4947 (is_marker_for) | |
| Disease | Bladder Neoplasm | 1.65e-06 | 140 | 42 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.71e-06 | 141 | 42 | 5 | C0005684 | |
| Disease | cystic fibrosis (is_marker_for) | 1.86e-06 | 62 | 42 | 4 | DOID:1485 (is_marker_for) | |
| Disease | Menke-Hennekam syndrome | 1.98e-06 | 2 | 42 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 1.98e-06 | 2 | 42 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 1.98e-06 | 2 | 42 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.98e-06 | 2 | 42 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.98e-06 | 2 | 42 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 1.98e-06 | 2 | 42 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 1.98e-06 | 2 | 42 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | cystitis (is_marker_for) | 1.98e-06 | 2 | 42 | 2 | DOID:1679 (is_marker_for) | |
| Disease | Rubinstein-Taybi Syndrome | 1.98e-06 | 2 | 42 | 2 | C0035934 | |
| Disease | Sjogren's syndrome (is_marker_for) | 5.32e-06 | 24 | 42 | 3 | DOID:12894 (is_marker_for) | |
| Disease | sputum mucin-5B amount | 5.93e-06 | 3 | 42 | 2 | OBA_2050332 | |
| Disease | Prostatic Neoplasms | 2.39e-05 | 616 | 42 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.39e-05 | 616 | 42 | 7 | C0376358 | |
| Disease | Carcinoma, Transitional Cell | 2.75e-05 | 41 | 42 | 3 | C0007138 | |
| Disease | Down syndrome (is_implicated_in) | 2.96e-05 | 6 | 42 | 2 | DOID:14250 (is_implicated_in) | |
| Disease | cardiomyopathy (is_marker_for) | 4.13e-05 | 7 | 42 | 2 | DOID:0050700 (is_marker_for) | |
| Disease | Small cell carcinoma of lung | 6.32e-05 | 54 | 42 | 3 | C0149925 | |
| Disease | Diffuse Large B-Cell Lymphoma | 6.68e-05 | 55 | 42 | 3 | C0079744 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 7.08e-05 | 9 | 42 | 2 | EFO_0009824 | |
| Disease | prostate cancer (is_marker_for) | 7.19e-05 | 156 | 42 | 4 | DOID:10283 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 9.11e-05 | 61 | 42 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 9.11e-05 | 61 | 42 | 3 | C1961102 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 1.08e-04 | 11 | 42 | 2 | EFO_0008209 | |
| Disease | pulmonary fibrosis | 1.08e-04 | 11 | 42 | 2 | EFO_0009448 | |
| Disease | neuroimaging measurement | 1.14e-04 | 1069 | 42 | 8 | EFO_0004346 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.29e-04 | 12 | 42 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | esophagus adenocarcinoma (is_marker_for) | 1.29e-04 | 12 | 42 | 2 | DOID:4914 (is_marker_for) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.29e-04 | 12 | 42 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.32e-04 | 69 | 42 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | colon carcinoma (is_marker_for) | 1.53e-04 | 13 | 42 | 2 | DOID:1520 (is_marker_for) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.62e-04 | 74 | 42 | 3 | DOID:3748 (is_marker_for) | |
| Disease | gastric ulcer (implicated_via_orthology) | 1.78e-04 | 14 | 42 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | Lymphoma, Large-Cell, Follicular | 2.05e-04 | 15 | 42 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 2.05e-04 | 15 | 42 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 2.05e-04 | 15 | 42 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 2.05e-04 | 15 | 42 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 2.05e-04 | 15 | 42 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 2.05e-04 | 15 | 42 | 2 | C1956130 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.05e-04 | 15 | 42 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | T-Cell Lymphoma | 2.34e-04 | 16 | 42 | 2 | C0079772 | |
| Disease | brain connectivity measurement | 2.51e-04 | 400 | 42 | 5 | EFO_0005210 | |
| Disease | sinusitis (is_marker_for) | 2.98e-04 | 18 | 42 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | Squamous cell carcinoma of esophagus | 3.39e-04 | 95 | 42 | 3 | C0279626 | |
| Disease | Inhalant adrenergic use measurement | 3.49e-04 | 96 | 42 | 3 | EFO_0009941 | |
| Disease | cup-to-disc ratio measurement | 3.50e-04 | 430 | 42 | 5 | EFO_0006939 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 3.60e-04 | 97 | 42 | 3 | DOID:3083 (is_marker_for) | |
| Disease | glaucoma (is_marker_for) | 3.70e-04 | 20 | 42 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Lymphoma, Follicular | 3.70e-04 | 20 | 42 | 2 | C0024301 | |
| Disease | Adenoid Cystic Carcinoma | 3.94e-04 | 100 | 42 | 3 | C0010606 | |
| Disease | pancreatic cancer (is_marker_for) | 4.06e-04 | 101 | 42 | 3 | DOID:1793 (is_marker_for) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 4.08e-04 | 21 | 42 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | systemic scleroderma (is_implicated_in) | 5.35e-04 | 24 | 42 | 2 | DOID:418 (is_implicated_in) | |
| Disease | colon adenocarcinoma (is_marker_for) | 5.81e-04 | 25 | 42 | 2 | DOID:234 (is_marker_for) | |
| Disease | primary biliary cholangitis (is_marker_for) | 5.81e-04 | 25 | 42 | 2 | DOID:12236 (is_marker_for) | |
| Disease | eosinophil percentage of leukocytes | 6.18e-04 | 746 | 42 | 6 | EFO_0007991 | |
| Disease | adult onset asthma | 6.39e-04 | 118 | 42 | 3 | EFO_1002011 | |
| Disease | Sezary Syndrome | 6.79e-04 | 27 | 42 | 2 | C0036920 | |
| Disease | Squamous cell carcinoma | 7.38e-04 | 124 | 42 | 3 | C0007137 | |
| Disease | asthma (is_marker_for) | 7.73e-04 | 126 | 42 | 3 | DOID:2841 (is_marker_for) | |
| Disease | irritable bowel syndrome | 8.65e-04 | 131 | 42 | 3 | EFO_0000555 | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 1.02e-03 | 33 | 42 | 2 | DOID:4467 (is_marker_for) | |
| Disease | eosinophil count | 1.04e-03 | 1488 | 42 | 8 | EFO_0004842 | |
| Disease | stomach cancer (is_marker_for) | 1.09e-03 | 142 | 42 | 3 | DOID:10534 (is_marker_for) | |
| Disease | Inflammatory Bowel Diseases | 1.14e-03 | 35 | 42 | 2 | C0021390 | |
| Disease | COVID-19 symptoms measurement | 1.14e-03 | 35 | 42 | 2 | EFO_0600019 | |
| Disease | respiratory system disease | 1.16e-03 | 145 | 42 | 3 | EFO_0000684 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLPSPTPATPTTPTG | 1846 | Q09472 | |
| PVSSSGQTPTPTPGS | 891 | Q92793 | |
| PSTTSSGGGTGPHPP | 491 | Q9HBB8 | |
| GSKSSGPPPPSGSSG | 11 | Q14444 | |
| SPPSPGTTTPGHTRG | 3521 | Q9HC84 | |
| STTNLPGSPGSPGSP | 761 | Q6IN85 | |
| STPPSSGPGMSTPPF | 601 | Q8IYY4 | |
| AGPTGPPTAGPSTAT | 491 | P14780 | |
| SPPTGTTPISSTGPV | 1801 | Q6W4X9 | |
| PPTGSSPFSSTGPMT | 1971 | Q6W4X9 | |
| GATSPPRGGPSTPST | 271 | Q9BQK8 | |
| PTPGEGTSTSVPPTA | 166 | Q9HCI5 | |
| PSTSVPATPGEGPST | 256 | Q9HCI5 | |
| SSTSVPPTPGGGLST | 316 | Q9HCI5 | |
| STSVPPTPGEGPSTS | 341 | Q9HCI5 | |
| GGPSASMSPGPTIPS | 21 | Q8N5M1 | |
| PGTTGTPDPGTTGTP | 46 | O43451 | |
| TPDPGTTGTPDPGTT | 51 | O43451 | |
| RTTGPPDPGTTGTTP | 71 | O43451 | |
| SGTPSPGSGTSSPSS | 66 | Q2KJY2 | |
| SSPSSFTGSPGPASP | 76 | Q2KJY2 | |
| RSGKSPSPSPTSPGS | 326 | O15075 | |
| TTGPSPGVTGTTGTP | 3396 | Q7Z5P9 | |
| APPSTPTAPTTTSGG | 4251 | Q02817 | |
| PPSTTTSPPGTPTRG | 4271 | Q02817 | |
| TSPPGTPTRGTTTGS | 4276 | Q02817 | |
| VTPTPGSVGGSTGPS | 286 | Q9ULI4 | |
| GSISSPTSPTSPGPQ | 16 | P49279 | |
| SGDPSLSPTGSTPTP | 421 | O75023 | |
| GTSPPTPTPSTATGG | 491 | Q9UMN6 | |
| SPASTTSGPGNTPSP | 2296 | P98088 | |
| TSGPGNTPSPVPTTS | 2301 | P98088 | |
| PTSSTTSGPGTTPSP | 2336 | P98088 | |
| TSGPGTTPSPVPTTS | 2341 | P98088 | |
| SGPGTTPSPVPTTST | 2446 | P98088 | |
| SGPGTTPSPVPTTST | 2566 | P98088 | |
| STTSGPGTTPSPVPT | 2651 | P98088 | |
| STTSGPGTTPSPVPT | 2691 | P98088 | |
| TTSGPGTTPSPVPTT | 2876 | P98088 | |
| STTSGPGTTPSPVPT | 2971 | P98088 | |
| TSGPGTTPSPVPTTS | 3061 | P98088 | |
| STTSTTPGPGTTPSP | 3176 | P98088 | |
| TPGPGTTPSPVPTTS | 3181 | P98088 | |
| SGPGTTPSPVPSTST | 4251 | P98088 | |
| SGPGTTPSPVPTTST | 4291 | P98088 | |
| TSTTSGPGTTPSPVP | 4311 | P98088 | |
| GPGTTPSPVPTTSTT | 4316 | P98088 | |
| STTSGPGSTPSPVPT | 4336 | P98088 | |
| SGPGTTPSPVPTTST | 4371 | P98088 | |
| TTSGPGSTPSPVPTT | 4401 | P98088 | |
| ASTTSGPGTTPSPVP | 4431 | P98088 | |
| GPGTTPSPVPTTSTT | 4436 | P98088 | |
| TSMTSGPGTTPSPVP | 4471 | P98088 | |
| GPGTTPSPVPTTSTT | 4476 | P98088 | |
| TSGPGTTPSPVPTTS | 4506 | P98088 | |
| TTSGPGTTPSPVPTT | 4561 | P98088 | |
| PTTSTTSGPGTTPSP | 4581 | P98088 | |
| TSGPGTTPSPVPTTS | 4586 | P98088 | |
| PTPPSSPSVSGGLSS | 721 | Q86VP3 | |
| SPSGSPGDPSSPTSS | 536 | Q3MIN7 | |
| PGDPSSPTSSVSPGS | 541 | Q3MIN7 | |
| VPPPLSSSPGGTSPS | 241 | Q9NXE4 | |
| SSSPGGTSPSPPPRT | 246 | Q9NXE4 | |
| PSTPSGPESGPTPAS | 176 | P49006 | |
| TPASSTAPPISSGPG | 351 | P55317 | |
| TGSFPTGPMPPTTST | 391 | P15976 | |
| IAPAPSSTPGSSTPG | 6 | O75956 | |
| SSTPGSSTPGPGTPV | 11 | O75956 | |
| SSTPGPGTPVPTGSV | 16 | O75956 | |
| PTGSVPSPSGSVPGA | 26 | O75956 | |
| QASPTSPGGSPSSPS | 3506 | Q03164 | |
| PSPTPSSSWSPGGGG | 291 | Q17RY0 | |
| GPTGPASPVGPTSST | 381 | Q9Y613 | |
| GVSPASRPSPGTPTS | 471 | Q5VT52 | |
| SSGGSGVPFSTPPPP | 1281 | Q5VT52 | |
| GGTVSPPPGTSRSAP | 736 | Q16584 | |
| PGASTTSTPGASPAP | 246 | Q504T8 | |
| PGVTSGPSASGTPPS | 741 | O15211 | |
| GPSGGPSSPTTGPTS | 421 | Q8NHL6 | |
| PSSPTTGPTSTSGPE | 426 | Q8NHL6 | |
| TCPSTSTPPAGPGTS | 1051 | Q9P2R6 | |
| GPPSPPSTATSFGGP | 1856 | Q6ZRS2 | |
| PMTPTSGGSTPPGIT | 311 | Q9BZC1 | |
| GTPSSASPTGTPPRA | 126 | Q9UF83 | |
| ASPTGTPPRASPTGT | 131 | Q9UF83 | |
| SSPVGSPVSPSAGGP | 551 | Q86YV5 | |
| PGGVGAPSSSSPSPS | 1161 | Q92797 | |
| SPWTGSGGTTPSTPT | 1971 | O14686 |